IN-VIVO EVALUATION OF SPRAY FORMULATIONS OF HUMAN INSULIN FOR NASAL DELIVERY

被引:40
|
作者
DONDETI, P [1 ]
ZIA, HS [1 ]
NEEDHAM, TE [1 ]
机构
[1] UNIV RHODE ISL,COLL PHARM,DEPT PHARMACEUT,KINGSTON,RI 02881
关键词
INSULIN; HUMAN; NASAL ADMINISTRATION; SPRAY FORMULATION; BIOADHESIVE POLYMER; MICROCRYSTALLINE CELLULOSE; PLASTOID; AMMONIUM GLYCYRRHIZINATE; GLYCYRRHETINIC ACID; SODIUM TAUROCHOLATE;
D O I
10.1016/0378-5173(95)00045-K
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There are many ongoing investigations to improve the nasal bioavailability of peptide and protein formulations. The presence of bioadhesive polymers in nasal formulations may increase the residence time of the drugs in the nasal cavity. A combination of bioadhesive polymers with permeation enhancers would seem to further improve nasal bioavailability. In this study, insulin spray formulations containing two bioadhesive polymers (1.5% w/v microcrystalline cellulose (MCC) and 70% w/w Plastoid L50) alone or in combination with the enhancers such as sodium taurocholate (ST), ammonium glycyrrhizinate (AG) or glycyrrhetinic acid (GA) at 1% w/v level, were evaluated in diabetic rabbits. A total volume of 100 mu l of freshly prepared insulin formulation was sprayed into the nasal cavity of each diabetic rabbit. Glucose levels were monitored using a blood glucose assay and serum insulin levels were analyzed using RIA. 5 U/kg insulin in the MCC suspension alone resulted in an absolute bioavailability of 1.96% while Plastoid L50 alone resulted in 2.25% absolute bioavailability. Insulin in the MCC suspension and ST, AG or GA resulted in 8.36, 7.83 and 2.15% bioavailability, respectively. The same formulations produced a hypoglycemic effect in terms of total glucose reductions of 39.12, 15.96 and 9.36% and the maximal decreases in glucose levels were 58.37, 21.8 and 18.61%, respectively. The Plastoid formulation containing 1% ST provided nasal insulin bioavailability of 5.9% with a total glucose reduction of 17.03% and a maximal glucose decrease of 26.56%. Insulin spray formulations containing 1% ST alone and 1% AG alone resulted in bioavailabilities of 7.25 and 3.57%, respectively. These same sprays provided total glucose reductions of 25.08 and 16.97% with maximal glucose decreases of 44.56 and 19.81%, respectively. The presence of benzalkonium chloride and 2-phenylethanol as preservatives in the MCC suspension resulted in higher insulin absorption than the same formulation without preservatives (6.31% vs 1.96%).
引用
收藏
页码:91 / 105
页数:15
相关论文
共 50 条
  • [21] THE EVALUATION OF PESTICIDE INGREDIENTS AND FORMULATIONS IN-VITRO AND CORRELATIONS WITH IN-VIVO DATA
    CLOTHIER, RH
    MORRIS, J
    LANKFORD, WT
    ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 1995, 23 (05): : 667 - 675
  • [22] In-vitro and in-vivo evaluation of two formulations of olanzapine compared to Zyprexa
    Ansari, M.
    Kazemipoor, M.
    Esmaeelzadeh, M.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 : S36 - S36
  • [23] Metoclopramide nasal spray in vitro evaluation and in vivo pharmacokinetic studies in dogs
    Li, Ying
    Fan, Xianpeng
    Li, Wanqing
    Yang, Peng
    Zhang, Hui
    Tang, Daoquan
    Yin, Xiaoxin
    Sun, Jianxu
    Zheng, Aiping
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2018, 23 (03) : 275 - 281
  • [24] A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation
    Nazar, H.
    Caliceti, P.
    Carpenter, B.
    El-Mallah, A. I.
    Fatouros, D. G.
    Roldo, M.
    van der Merwe, S. M.
    Tsibouklis, J.
    BIOMATERIALS SCIENCE, 2013, 1 (03) : 306 - 314
  • [25] DIABETES NURSING - INSULIN AS A NASAL SPRAY
    不详
    AMERICAN JOURNAL OF NURSING, 1987, 87 (08) : 1011 - 1011
  • [26] Development and evaluation of anthrax vaccine powder formulations for nasal mucosal delivery.
    Jiang, G
    Sullivan, V
    Mikszta, J
    Joshi, S
    Middaugh, CR
    Huang, J
    Alarcon, J
    Ferriter, M
    Woodley, W
    Ford, B
    Mar, K
    Roy, C
    Ulrich, R
    Harvey, N
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U201 - U201
  • [27] Ocular delivery systems for poorly soluble drugs: An in-vivo evaluation
    Luschmann, C.
    Herrmann, W.
    Strauss, O.
    Luschmann, K.
    Goepferich, A.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 455 (1-2) : 331 - 337
  • [28] In vivo systemic evaluation of nasal drug absorption from powder formulations in rats
    Tatsuta, Ryosuke
    Tanaka, Akiko
    Ogawara, Ken-ichi
    Higaki, Kazutaka
    Furubayashi, Tomoyuki
    Sakane, Toshiyasu
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2025, 207
  • [29] In Vitro, Ex Vivo and In Vivo Evaluation of Microcontainers for Oral Delivery of Insulin
    Jorgensen, Jacob Rune
    Yu, Feiyang
    Venkatasubramanian, Ramakrishnan
    Nielsen, Line Hagner
    Nielsen, Hanne Morck
    Boisen, Anja
    Rades, Thomas
    Mullertz, Anette
    PHARMACEUTICS, 2020, 12 (01)
  • [30] Equivalence of Nasal Spray and Subcutaneous Formulations of Salmon Calcitonin
    B. Combe
    C. Cohen
    F. Aubin
    Calcified Tissue International, 1997, 61 : 10 - 15